ElizabethAnneRicheyMD

Internal Medicine • New Haven, CT

Primary Care Physician

Join to view full profile

Dr. Richey is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Richey's full profile

Already have an account?

Office
55 Lock St
New Haven, CT 06511

Education & Training

Brigham and Women's HospitalResidency, Internal Medicine, 2014 - 2017
Geisel School of Medicine at DartmouthClass of 2014

Certifications & Licensure

CT State Medical License 2017 - 2025
MA State Medical License 2014 - 2017
American Board of Internal Medicine Internal Medicine
American Board of Obesity Medicine Obesity Medicine

Awards, Honors, & Recognition

Inductee Alpha Omega Alpha Honor Medical Society

Publications & Presentations

PubMed

663 citations
Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports ...
Kenneth R. Carson, Andrew M. Evens, Elizabeth A. Richey, Thomas M. Habermann, Daniele Focosi
Blood. 2009-05-14
58 citations
Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (198...
Anaadriana Zakarija, Hau C. Kwaan, Joel L. Moake, Nicholas Bandarenko, Dilip K. Pandey
Kidney International. Supplement. 2009-02-01
337 citations
Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research o...
Kenneth R. Carson, Daniele Focosi, Eugene O. Major, Mario Petrini, Elizabeth A. Richey
The Lancet. Oncology. 2009-08-01

Press Mentions

A Symptom-Based Rule for Diagnosis of COVID-19October 24th, 2020